- “Dapagliflozin Tablets” already exists in your wishlist
In Stock
Abiraterone Acetate Tablets
Abiraterone Acetate Tablets 250mg | Anti-Cancer
- Product Form: Raw Powder / API
- Not for direct consumer use
- For qualified buyers, formulation, compounding, R&D, and regulated business use only
- COA/MSDS available upon request
- Final sale depends on buyer country import regulations
Disclaimer: Products listed on this website are intended for qualified business buyers, research, formulation, compounding, or regulated pharmaceutical use only. Products are not intended for direct consumer use. Import permission, registration, customs clearance, and local regulatory compliance are the responsibility of the buyer in their respective country.
Description
Generic medicine information • For patient education
Product Introduction
Abiraterone acetate 250 mg is a prescription hormonal anti-cancer medicine used for selected adult patients with prostate cancer. It reduces production of androgens (male hormones such as testosterone), which can stimulate prostate cancer growth. It is commonly prescribed with a corticosteroid such as prednisone or prednisolone, as directed by the oncologist.
The 250 mg strength indicates the amount in each tablet. The number of tablets and treatment schedule must be determined by the treating specialist; do not adjust the dose yourself.
1. Uses
Used to treat selected forms of prostate cancer in adults, according to the disease stage and treatment plan prescribed by the oncologist.
It is often used with another prescribed medicine, such as prednisone or prednisolone, and may be used alongside other prostate-cancer treatments depending on the clinical situation.
2. Benefits
Reduces androgen production by inhibiting the CYP17 enzyme involved in making testosterone and related hormones.
Lower androgen levels can slow the growth of prostate cancer cells and may help control disease progression in appropriate patients.
Benefits vary by patient. It is not a guaranteed cure, and regular follow-up is important.
3. Side Effects
Common or reported side effects include swelling (oedema), fatigue, nausea or vomiting, diarrhoea, high blood pressure, low potassium levels, joint discomfort or swelling, hot flushes, cough, urinary tract infection, anaemia, and changes in liver enzymes.
Serious risks can include liver injury, severe low potassium, fluid retention, high blood pressure, and heart-related complications.
Seek urgent medical help for yellowing of the skin or eyes, dark urine, severe or persistent vomiting, fainting, marked weakness, irregular heartbeat, chest pain, sudden breathlessness, or severe swelling.
4. Safety Advice
Tell your oncologist if you have liver disease, heart disease, high blood pressure, low potassium, diabetes, or kidney problems, and share a full list of your medicines.
Regular monitoring may include liver function tests, blood pressure, potassium levels, fluid retention, and blood glucose, as advised by your doctor.
Pregnancy: this medicine can harm an unborn baby. It should not be handled by someone who is pregnant or may become pregnant without appropriate protective precautions. Follow the product leaflet and clinician’s advice.
Breastfeeding: this medicine is not intended for use by women. Follow specialist and product-leaflet advice about exposure precautions.
Do not stop or change prednisone/prednisolone or any other accompanying medicine without your prescriber’s instructions.
Alcohol: ask your clinician whether alcohol is appropriate during treatment.
Storage: store below 30°C, in the original packaging and out of reach of children, unless the product label states otherwise.
5. How It Works
Abiraterone acetate is converted in the body to abiraterone, which blocks CYP17, an enzyme needed for androgen production. Reducing these hormones can slow the growth of prostate cancer cells.
6. How to Use
Take exactly as prescribed by your oncologist. Swallow the tablet whole with water; do not crush, chew, or break it.
Take on an empty stomach: at least 1 hour before food or at least 2 hours after food. Taking it with food can increase and make absorption unpredictable.
Take prednisone or prednisolone only as prescribed alongside this treatment, if included in your regimen.
If you miss a dose, follow the package leaflet or contact your oncology team. Do not take a double dose to make up for a missed dose.
Do not stop treatment or alter the dose without consulting your oncologist.
7. Quick Tips
Attend all scheduled visits and blood tests, especially liver function, blood pressure, and potassium monitoring.
Report yellow skin/eyes, dark urine, severe nausea, loss of appetite, unusual tiredness, or abdominal pain promptly.
Report new swelling, rapid weight gain, muscle weakness, palpitations, or shortness of breath.
Tell your healthcare team about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements before starting anything new.
Use effective contraception as advised by your specialist to avoid exposing a partner to the medicine; follow the product leaflet for specific precautions.
Keep the medicine in its original packaging and away from children.
8. Drug Interactions
Abiraterone can interact with medicines that affect liver enzymes or heart rhythm, and it may alter the effects of some other medicines.
Some medicines, including certain anti-arrhythmics such as amiodarone, may require careful review and monitoring. This is not a complete interaction list.
Do not start, stop, or change any medicine or supplement without checking with your oncologist or pharmacist.
Medical Disclaimer
This document is for general patient education only and is not a substitute for advice from a qualified doctor, oncology specialist, or pharmacist. Abiraterone acetate is a prescription anti-cancer medicine and must be used only under specialist supervision. The correct indication, dose, accompanying medicines, food timing, monitoring, and management of side effects depend on the individual patient and current approved product information. In an emergency, seek urgent medical care.
| Product Name | Abiraterone Acetate Tablets |
| Category | All Medicines, Anti Cancer |
| Form | Raw Powder |
| Grade | As per available specification |
| Documents | COA, MSDS, Invoice, Packing List |
| Packing | As per order quantity |
| MOQ | On request |
| Shipment | Air cargo / courier / buyer-approved route |
| Use | B2B, formulation, compounding, research & qualified buyer supply |
| Disclaimer | Subject to buyer country regulations |
Additional information
| Strength | 250mg |
|---|
Customer Reviews
Only logged in customers who have purchased this product may leave a review.
